.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Frontline Eltrombopag for Severe Aplastic Anemia

EP. 1: Frontline Shift for Severe Aplastic Anemia After Eltrombopag FDA Approval

December 26th 2018

EP. 2: Treatment Plan Criteria and Second-Line Options

December 26th 2018

EP. 3: Immunotherapy After Initial Resistance

December 26th 2018

EP. 4: Mechanisms of Action of Eltrombopag

December 26th 2018

EP. 5: Eltrombopag Trial and Treatment Discontinuation

December 26th 2018

EP. 6: Transplantation in Patients With Severe Aplastic Anemia

December 26th 2018

EP. 7: The Role of Supportive Care in Severe Aplastic Anemia

December 26th 2018

EP. 8: Unmet Needs in Severe Aplastic Anemia and Exciting Ongoing Developments

December 26th 2018